Develops small-molecule covalent therapies (targeting GPCRs) for autoimmune and inflammatory disorders.
| Date | Round | Amount |
|---|---|---|
| Nov 2023 | Seed Leiden-based Artica Therapeutics raised a EUR12M seed co-led by Thuja Capital and Seroba for its covalent small-molecule pipeline. | $12.9M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.